Latest in Novo Nordisk Nudges
Sort by
17 items
-
Ozempic maker Novo Nordisk nudges higher profit forecast
Novo Nordisk on Wednesday nudged higher its outlook for the year as the drugmaker registered another quarter of strong sales of its weight-loss drugs.Business - MarketWatch - 6 hours ago -
With Novo Nordisk success, is there a "Nokia risk" for Denmark?
Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the Danish economy.Top stories - CBS News - 2 days ago -
Novo Nordisk's Wegovy Sales Beat Expectations
The pharmaceutical giant narrowed its full-year guidance after its blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter.Business - The Wall Street Journal - 11 hours ago -
Novo Nordisk New Pill Reduces Heart Attacks, Strokes in Diabetic Patients
The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.Business - The Wall Street Journal - October 21 -
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.Top stories - CBS News - 2 days ago -
Novo Nordisk's obesity-fighting drugs fatten Denmark's economy
Danish company Novo Nordisk has a market cap larger than the entire country's GDP. As it grows, it's having an impact on other industries.Top stories - CBS News - 2 days ago -
Weight loss drug industry injects wealth into Novo Nordisk home country
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.Top stories - CBS News - 2 days ago -
Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.Business - CNBC - 9 hours ago -
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely.Business - CNBC - October 23 -
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats
Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...Politics - The Hill - October 23 -
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.Business - CNBC - October 24 -
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.Business - CNBC - 6 days ago -
A glance at Ukraine's plan aimed at nudging Russia into talks to end the war
Ukraine’s President Volodymyr Zelenskyy has partially revealed his five-point plan aimed at prompting Russia to end the war through negotiationsWorld - ABC News - October 16 -
The Land Of Novo I Sunday on 60 Minutes
Denmark—home to some of the world's wealthiest and healthiest people—is now home to Europe's largest company, Novo Nordisk. The company's weight loss wonder drugs Ozempic and Wegovy have slimmed ...Top stories - CBS News - 5 days ago -
11/03/2024: Election Truth; Unintended Consequences; The Land of Novo
First, how Georgia election officials fight voting misinformation. Then, a look at the consequences of Texas' strict abortion laws. And, meet the Novo Nordisk scientist behind Ozempic, Wegovy.Top stories - CBS News - 2 days ago
